Rhythm Pharmaceuticals Stock
Price
Target price
€53.50
€53.50
-
-
-
€62.95
13.06.25 / Stuttgart Stock Exchange
WKN: A2H5A0 / Symbol: RYTM / Name: Rhythm Pharmaceuticals / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Rhythm Pharmaceuticals Stock
With 28 Buy predictions and not a single Sell prediction Rhythm Pharmaceuticals is an absolute favorite of our community.
As a result the target price of 62 € shows a slightly positive potential of 15.89% compared to the current price of 53.5 € for Rhythm Pharmaceuticals.
For the coming years our community has positive and negative things to say abot the Rhythm Pharmaceuticals stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of Rhythm Pharmaceuticals in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Rhythm Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals | - | -6.140% | 1.905% | 36.288% | 2.392% | 1531.098% | 202.260% |
| Krystal Biotech | -1.400% | -1.083% | 1.757% | -28.507% | -21.978% | 132.843% | - |
| Ardelyx Inc. | -0.560% | -0.744% | 5.748% | -46.002% | -35.529% | 521.071% | -45.282% |
| Evolus Inc | -1.730% | 3.030% | -3.955% | -19.048% | -19.048% | -23.423% | 95.853% |
Comments
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at Stifel Nicolaus from $78.00 to $94.00. They now have a "buy" rating on the stock.
Show more
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at Needham & Company LLC from $66.00 to $72.00. They now have a "buy" rating on the stock.
Show more
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock, up previously from $70.00.
Show more
Ratings data for RYTM provided by MarketBeat